Document is current
Any future updates will be listed below
-
Authors
Philpott, Martin
Watson, Jonathan
Thakurta, Anjan
Brown, Tom Jr https://orcid.org/0000-0002-8607-1226
Brown, Tom Sr https://orcid.org/0000-0002-6538-3036
Oppermann, Udo https://orcid.org/0000-0001-9984-5342
Cribbs, Adam P. https://orcid.org/0000-0001-5288-3077
-
Funding
Funding for this research was provided by:
Cancer Research UK
DH | NIHR | Health Services Research Programme
Bone Cancer Research Trust
DH | National Institute for Health Research
Fondation Leducq
RCUK | MRC | Medical Research Foundation (MR/V010182/1)
- License Information
-
More Information
Article History
Received: 18 January 2021
Accepted: 21 May 2021
First Online: 1 July 2021
Competing interests
: A.T. is a full-time employee and shareholder of Bristol Myers Squibb and visiting professor, Weatherall Institute of Molecular Medicine, University of Oxford. M.P., U.O. and A.P.C. are inventors on patents filed by Oxford University Innovations for single-cell technologies and are founders of Caeruleus Genomics. T.B. Jr. is a director and shareholder of ATDBio. T.B. Sr. is a director of ATDBio. The other authors declare no competing interests.
